Pfizer Wants FDA To Stop Sponsor Promos From Implying Biosimilars Are Inferior
Executive Summary
Citizen petition requests agency guidance that specifies what communications are false and misleading; Pfizer cites a Janssen Remicade brochure and Amgen YouTube video that suggest switching to biosimilars could lead to different outcomes.